US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 10.120
  • +0.010+0.10%
Close Nov 29 13:00 ET
  • 10.160
  • +0.040+0.40%
Post 17:01 ET
548.34MMarket Cap-2588P/E (TTM)

Emergent BioSolutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
156.17%153.7M
141.52%47.5M
65.98%-62.6M
-504.99%-206.3M
-65.41%32.1M
181.08%60M
-633.33%-114.4M
-393.30%-184M
-110.65%-34.1M
-71.72%92.8M
Net income from continuing operations
143.58%114.8M
-8.30%-283.1M
104.83%9M
-259.40%-760.5M
26.12%-49.5M
-211.72%-263.4M
-363.48%-261.4M
-4,932.43%-186.2M
-196.40%-211.6M
-137.66%-67M
Operating gains losses
-404.11%-44.4M
----
----
---74.2M
---13.9M
--14.6M
----
----
----
----
Depreciation and amortization
-5.71%26.4M
-13.37%28.5M
-19.36%27.9M
-12.70%125.1M
-17.09%29.6M
-13.04%28M
-26.07%32.9M
11.97%34.6M
15.75%143.3M
22.26%35.7M
Deferred tax
170.37%7.3M
88.24%-200K
-159.57%-12.2M
68.88%-8.9M
90.39%-5.2M
-88.21%2.7M
-342.86%-1.7M
-347.37%-4.7M
-162.17%-28.6M
-219.16%-54.1M
Other non cash items
-84.85%-18.3M
28.11%23.7M
168.75%4.3M
163.36%34.5M
550.00%24.3M
-179.20%-9.9M
374.36%18.5M
-23.81%1.6M
45.56%13.1M
93.86%-5.4M
Change In working capital
-0.30%65.6M
244.19%205.9M
-170.08%-97.5M
-3,247.62%-70.3M
-74.09%42.8M
196.34%65.8M
-593.20%-142.8M
53.95%-36.1M
98.55%-2.1M
28.16%165.2M
-Change in receivables
15.43%82.3M
115.41%20.4M
-2,023.08%-50M
-118.29%-21.6M
3.65%36.9M
569.08%71.3M
-3,410.00%-132.4M
-97.23%2.6M
829.01%118.1M
-63.86%35.6M
-Change in inventory
-17,900.00%-18M
-324.14%-13M
85.34%-4.5M
101.05%600K
-43.98%25.6M
99.63%-100K
122.83%5.8M
38.72%-30.7M
14.26%-57.1M
631.40%45.7M
-Change in prepaid assets
-2,640.00%-13.7M
1,348.12%166M
-33.33%-6M
158.79%11.7M
108.33%30M
96.64%-500K
-375.00%-13.3M
72.89%-4.5M
-358.44%-19.9M
-76.96%14.4M
-Change in payables and accrued expense
60.00%3.2M
532.88%31.6M
-332.50%-34.6M
31.90%-55.5M
-170.51%-42.2M
125.64%2M
-118.34%-7.3M
91.83%-8M
-1,098.53%-81.5M
-177.61%-15.6M
-Change in other working capital
271.01%11.8M
-79.55%900K
-153.33%-2.4M
-114.36%-5.5M
-108.81%-7.5M
-122.58%-6.9M
112.15%4.4M
160.00%4.5M
160.70%38.3M
295.18%85.1M
Cash from discontinued investing activities
Operating cash flow
156.17%153.7M
141.52%47.5M
65.98%-62.6M
-504.99%-206.3M
-65.41%32.1M
181.08%60M
-633.33%-114.4M
-393.30%-184M
-110.65%-34.1M
-71.72%92.8M
Investing cash flow
Cash flow from continuing investing activities
692.59%112M
-101.79%-4.6M
28.48%-10.8M
155.68%212.3M
74.89%-11.4M
93.04%-18.9M
902.80%257.7M
53.11%-15.1M
-70.15%-381.3M
0.87%-45.4M
Net PPE purchase and sale
114.29%1.8M
63.20%-4.6M
28.48%-10.8M
55.44%-51.6M
51.69%-11.4M
54.84%-12.6M
61.06%-12.5M
53.11%-15.1M
48.33%-115.8M
48.47%-23.6M
Net business purchase and sale
--110.2M
----
----
--270.2M
--0
--0
----
----
--0
--0
Net other investing changes
----
----
----
97.63%-6.3M
--0
----
----
----
---265.5M
---21.8M
Cash from discontinued investing activities
Investing cash flow
692.59%112M
-101.79%-4.6M
28.48%-10.8M
155.68%212.3M
74.89%-11.4M
93.04%-18.9M
902.80%257.7M
53.11%-15.1M
-70.15%-381.3M
0.87%-45.4M
Financing cash flow
Cash flow from continuing financing activities
-319.30%-180.3M
89.55%-50.9M
487.62%40.7M
-211.33%-535.7M
-98.67%4.7M
-118.75%-43M
-1,485.99%-486.9M
85.11%-10.5M
441.28%481.2M
420.42%353.1M
Net issuance payments of debt
-352.21%-194M
90.83%-45.5M
589.29%41.1M
-196.31%-543.4M
-98.83%4.1M
-118.68%-42.9M
-5,807.14%-496.2M
1.18%-8.4M
1,671.59%564.2M
4,284.52%351.5M
Net common stock issuance
--9.3M
----
----
110.23%8.4M
200.00%200K
--0
----
----
22.55%-82.1M
99.81%-200K
Proceeds from stock option exercised by employees
--13.4M
----
----
-64.00%1.8M
-75.00%500K
--0
----
----
-68.55%5M
-41.18%2M
Net other financing activities
-8,900.00%-9M
-2,950.00%-6.1M
80.95%-400K
57.63%-2.5M
50.00%-100K
66.67%-100K
50.00%-200K
58.00%-2.1M
60.67%-5.9M
-120.00%-200K
Cash from discontinued financing activities
Financing cash flow
-319.30%-180.3M
89.55%-50.9M
487.62%40.7M
-211.33%-535.7M
-98.67%4.7M
-118.75%-43M
-1,485.99%-486.9M
85.11%-10.5M
441.28%481.2M
421.00%353.1M
Net cash flow
Beginning cash position
-19.86%71M
-81.64%79M
-82.62%111.7M
11.50%642.6M
-63.57%87.8M
-75.27%88.6M
-1.33%430.2M
11.50%642.6M
-7.27%576.3M
-40.35%241M
Current changes in cash
4,594.74%85.4M
97.67%-8M
84.40%-32.7M
-905.02%-529.7M
-93.66%25.4M
98.37%-1.9M
-338.27%-343.6M
-49.71%-209.6M
246.55%65.8M
132.44%400.5M
Effect of exchange rate changes
--0
--0
--0
-340.00%-1.2M
-236.36%-1.5M
210.00%1.1M
-185.71%-600K
33.33%-200K
266.67%500K
--1.1M
End cash Position
78.13%156.4M
-19.86%71M
-81.64%79M
-82.62%111.7M
-82.62%111.7M
-63.57%87.8M
-75.27%88.6M
-1.33%430.2M
11.50%642.6M
11.50%642.6M
Free cash flow
212.03%147.9M
133.81%42.9M
63.13%-73.4M
-72.05%-257.9M
-70.09%20.7M
146.52%47.4M
-166.04%-126.9M
-186.47%-199.1M
-255.98%-149.9M
-75.49%69.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 156.17%153.7M141.52%47.5M65.98%-62.6M-504.99%-206.3M-65.41%32.1M181.08%60M-633.33%-114.4M-393.30%-184M-110.65%-34.1M-71.72%92.8M
Net income from continuing operations 143.58%114.8M-8.30%-283.1M104.83%9M-259.40%-760.5M26.12%-49.5M-211.72%-263.4M-363.48%-261.4M-4,932.43%-186.2M-196.40%-211.6M-137.66%-67M
Operating gains losses -404.11%-44.4M-----------74.2M---13.9M--14.6M----------------
Depreciation and amortization -5.71%26.4M-13.37%28.5M-19.36%27.9M-12.70%125.1M-17.09%29.6M-13.04%28M-26.07%32.9M11.97%34.6M15.75%143.3M22.26%35.7M
Deferred tax 170.37%7.3M88.24%-200K-159.57%-12.2M68.88%-8.9M90.39%-5.2M-88.21%2.7M-342.86%-1.7M-347.37%-4.7M-162.17%-28.6M-219.16%-54.1M
Other non cash items -84.85%-18.3M28.11%23.7M168.75%4.3M163.36%34.5M550.00%24.3M-179.20%-9.9M374.36%18.5M-23.81%1.6M45.56%13.1M93.86%-5.4M
Change In working capital -0.30%65.6M244.19%205.9M-170.08%-97.5M-3,247.62%-70.3M-74.09%42.8M196.34%65.8M-593.20%-142.8M53.95%-36.1M98.55%-2.1M28.16%165.2M
-Change in receivables 15.43%82.3M115.41%20.4M-2,023.08%-50M-118.29%-21.6M3.65%36.9M569.08%71.3M-3,410.00%-132.4M-97.23%2.6M829.01%118.1M-63.86%35.6M
-Change in inventory -17,900.00%-18M-324.14%-13M85.34%-4.5M101.05%600K-43.98%25.6M99.63%-100K122.83%5.8M38.72%-30.7M14.26%-57.1M631.40%45.7M
-Change in prepaid assets -2,640.00%-13.7M1,348.12%166M-33.33%-6M158.79%11.7M108.33%30M96.64%-500K-375.00%-13.3M72.89%-4.5M-358.44%-19.9M-76.96%14.4M
-Change in payables and accrued expense 60.00%3.2M532.88%31.6M-332.50%-34.6M31.90%-55.5M-170.51%-42.2M125.64%2M-118.34%-7.3M91.83%-8M-1,098.53%-81.5M-177.61%-15.6M
-Change in other working capital 271.01%11.8M-79.55%900K-153.33%-2.4M-114.36%-5.5M-108.81%-7.5M-122.58%-6.9M112.15%4.4M160.00%4.5M160.70%38.3M295.18%85.1M
Cash from discontinued investing activities
Operating cash flow 156.17%153.7M141.52%47.5M65.98%-62.6M-504.99%-206.3M-65.41%32.1M181.08%60M-633.33%-114.4M-393.30%-184M-110.65%-34.1M-71.72%92.8M
Investing cash flow
Cash flow from continuing investing activities 692.59%112M-101.79%-4.6M28.48%-10.8M155.68%212.3M74.89%-11.4M93.04%-18.9M902.80%257.7M53.11%-15.1M-70.15%-381.3M0.87%-45.4M
Net PPE purchase and sale 114.29%1.8M63.20%-4.6M28.48%-10.8M55.44%-51.6M51.69%-11.4M54.84%-12.6M61.06%-12.5M53.11%-15.1M48.33%-115.8M48.47%-23.6M
Net business purchase and sale --110.2M----------270.2M--0--0----------0--0
Net other investing changes ------------97.63%-6.3M--0---------------265.5M---21.8M
Cash from discontinued investing activities
Investing cash flow 692.59%112M-101.79%-4.6M28.48%-10.8M155.68%212.3M74.89%-11.4M93.04%-18.9M902.80%257.7M53.11%-15.1M-70.15%-381.3M0.87%-45.4M
Financing cash flow
Cash flow from continuing financing activities -319.30%-180.3M89.55%-50.9M487.62%40.7M-211.33%-535.7M-98.67%4.7M-118.75%-43M-1,485.99%-486.9M85.11%-10.5M441.28%481.2M420.42%353.1M
Net issuance payments of debt -352.21%-194M90.83%-45.5M589.29%41.1M-196.31%-543.4M-98.83%4.1M-118.68%-42.9M-5,807.14%-496.2M1.18%-8.4M1,671.59%564.2M4,284.52%351.5M
Net common stock issuance --9.3M--------110.23%8.4M200.00%200K--0--------22.55%-82.1M99.81%-200K
Proceeds from stock option exercised by employees --13.4M---------64.00%1.8M-75.00%500K--0---------68.55%5M-41.18%2M
Net other financing activities -8,900.00%-9M-2,950.00%-6.1M80.95%-400K57.63%-2.5M50.00%-100K66.67%-100K50.00%-200K58.00%-2.1M60.67%-5.9M-120.00%-200K
Cash from discontinued financing activities
Financing cash flow -319.30%-180.3M89.55%-50.9M487.62%40.7M-211.33%-535.7M-98.67%4.7M-118.75%-43M-1,485.99%-486.9M85.11%-10.5M441.28%481.2M421.00%353.1M
Net cash flow
Beginning cash position -19.86%71M-81.64%79M-82.62%111.7M11.50%642.6M-63.57%87.8M-75.27%88.6M-1.33%430.2M11.50%642.6M-7.27%576.3M-40.35%241M
Current changes in cash 4,594.74%85.4M97.67%-8M84.40%-32.7M-905.02%-529.7M-93.66%25.4M98.37%-1.9M-338.27%-343.6M-49.71%-209.6M246.55%65.8M132.44%400.5M
Effect of exchange rate changes --0--0--0-340.00%-1.2M-236.36%-1.5M210.00%1.1M-185.71%-600K33.33%-200K266.67%500K--1.1M
End cash Position 78.13%156.4M-19.86%71M-81.64%79M-82.62%111.7M-82.62%111.7M-63.57%87.8M-75.27%88.6M-1.33%430.2M11.50%642.6M11.50%642.6M
Free cash flow 212.03%147.9M133.81%42.9M63.13%-73.4M-72.05%-257.9M-70.09%20.7M146.52%47.4M-166.04%-126.9M-186.47%-199.1M-255.98%-149.9M-75.49%69.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday+0.54%